Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Five9 CFO Sells Common Stock in September 2026

Bryan M. Lee, Chief Financial Officer of Five9, Inc. (NASDAQ:FIVN), filed a Form 4 on September 9, 2026, disclosing four sales of common stock executed on September 4 and September 8, 2026.

Manish Choudhary | 09 September 2026

Frontier Group Holdings SVP Sells 3,480 Shares

Alexandre Clerc, Senior Vice President of Customers at Frontier Group Holdings, Inc., filed a statement of changes in beneficial ownership on September 9, 2026, disclosing a sale of common stock that occurred on September 4, 2026.

Anjali Anand | 09 September 2026

Frontier Group Holdings SVP Sells 7,500 Shares

Steve Schuller, Senior Vice President of Human Resources at Frontier Group Holdings, Inc., filed a Form 4 on September 9, 2026, disclosing the sale of 7,500 shares of common stock on September 4, 2026.

Shwetambri Chauhan | 09 September 2026

UroGen Pharma General Counsel Reports RSU Vesting and Share Sale

Jason Drew Smith, General Counsel of UroGen Pharma Ltd. (NASDAQ:URGN), filed a Form 4 on September 9, 2026, disclosing the vesting of restricted stock units and a subsequent sale of ordinary shares on September 7 and 8, 2026.

Shwetambri Chauhan | 09 September 2026

JFrog CTO Yoav Landman Sells Ordinary Shares in Five Tranches

JFrog Ltd Chief Technology Officer Yoav Landman filed a Form 4 with the SEC on September 9, 2026, disclosing the sale of ordinary shares on September 4, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Nitish Kishor | 09 September 2026

Alkami Technology CEO Reports RSU Tax Withholding Transaction

A statement of changes in beneficial ownership for Alkami Technology, Inc. (NASDAQ:ALKT) was filed on September 9, 2026, disclosing a share disposition by Chief Executive Officer Alex Shootman on September 8, 2026.

Manish Choudhary | 09 September 2026

UroGen Pharma CMO Reports RSU Vesting and Share Sale

Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. (NASDAQ:URGN), filed a Form 4 on September 9, 2026, reporting the vesting of restricted stock units and a subsequent sale of ordinary shares on September 7 and 8, 2026.

Aakashdeep | 09 September 2026

Agilent Technologies Director Reports Share Sale

Director Mikael Dolsten filed a statement of changes in beneficial ownership with the SEC on September 9, 2026, disclosing a sale of Agilent Technologies, Inc. common stock on September 4, 2026.

Vinay Lochav | 09 September 2026

National Vision CTO Reports RSU Vesting and Share Withholding

David G. Cutler, Chief Technology Officer of National Vision Holdings, Inc. (NASDAQ:EYE), filed a Form 4 on September 9, 2026, disclosing transactions in common stock and restricted stock units dated September 8, 2026.

Anjali Anand | 09 September 2026

Netflix Director Richard Barton Reports Stock Option Exercise and Sale

A Form 4 filed on September 9, 2026 discloses that Richard N. Barton, a director of Netflix Inc (NASDAQ:NFLX), exercised stock options and sold shares of common stock on September 8, 2026 pursuant to a Rule 10b5-1 trading plan.

Aakashdeep | 09 September 2026
Support

Hi! How can we help you today?

Loading…